100 East Pratt Street,
Baltimore , MD, 21202

Rank

Rank Universe
54 97

Summary

The fund seeks capital appreciation in the long term and current income by investing in large-size companies outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests a significant portion of its net assets in More

Link

Directors

Jan 12, 2024
  • Bruce W. Duncan
  • David Oestreicher
  • Eric L. Veiel
  • Kellye L. Walker
  • Mark J. Parrell
  • Melody Bianchetto
  • Paul F. McBride
  • Robert J. Gerrard, Jr.
  • Teresa Bryce Bazemore

Chief Compliance Officer

  • Armando Capasso

Fund Manager(s)

Price

  • $ 17.89 ( -0.08 )
    Oct 30, 2024
    Last Close
  • Net Assets
  • $10.5B
    Mar 28, 2024
  • Holding
  • 144
    Sep 27, 2024
    More

  • 52-Week High/Low
  • $18.74 - $14.57
  • Turnover
  • 22.2%
  • Expense Ratio
  • 1.31%

Company Name

Holding

T. Rowe Price Government Reserve Fund 3.55 %
AstraZeneca PLC 2.8 %
T. Rowe Price Government Reserve Fund 2.5 %
TotalEnergies SE 2.16 %
ING Groep NV 2.08 %
Rolls-Royce Holdings PLC 2.01 %
Sanofi SA 1.8 %
Roche Holding AG 1.76 %
Unilever PLC 1.67 %
AXA SA 1.64 %
More 1.64 %

Advisor

Documents

Prospectus

Annual Reports

Performance

YTD

2.1%

3 Year

14.83%

5 Year

28.52%

Best

39.4%

2003

Worst

-45.04%

2008

Alpha

RRIGX S&P 500

Chart +